1-20 of 1366
Section: Articles
Sort by
Journal Article
Recurrent pericarditis is less scary: the new therapeutic solutions
Rita Del Pinto and Claudio Ferri
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E83–E86, https://doi.org/10.1093/eurheartj/suab097
Published: 08 October 2021
Journal Article
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications
Gioele Fabbri and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E128–E132, https://doi.org/10.1093/eurheartj/suab107
Published: 08 October 2021
Journal Article
Treatment of carotid stenosis: surgery and stent in comparison
Rocco Giudice and Claudio Spataro
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E91–E94, https://doi.org/10.1093/eurheartj/suab099
Published: 08 October 2021
Journal Article
Clinical impact of myocardial fibrosis in severe aortic stenosis
Matteo Castrichini and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E147–E150, https://doi.org/10.1093/eurheartj/suab120
Published: 08 October 2021
Journal Article
Reflections after TWILIGHT study: a new era in secondary prevention without aspirin?
Giovanni Occhipinti and Davide Capodanno
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E45–E50, https://doi.org/10.1093/eurheartj/suab087
Published: 08 October 2021
Journal Article
Prevention of ischaemic events in subjects with polydistrict vascular disease
Giuseppe Patti and Chiara Ghiglieno
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E103–E108, https://doi.org/10.1093/eurheartj/suab102
Published: 08 October 2021
Journal Article
How to reduce uncommon but severe transcatheter aortic valve implantation complications: stroke, thrombosis, endocarditis, cognitive decline?
Francesco Saia and Mateusz Orzalkiewicz
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E142–E146, https://doi.org/10.1093/eurheartj/suab110
Published: 08 October 2021
Journal Article
The myosin activator: is another step forward in heart failure therapy?
Raffaele Abete and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E151–E155, https://doi.org/10.1093/eurheartj/suab114
Published: 08 October 2021
Journal Article
Moderate gradient severe aortic stenosis: diagnosis, prognosis and therapy
Vittoria Rizzello
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E133–E137, https://doi.org/10.1093/eurheartj/suab108
Published: 08 October 2021
Journal Article
Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease
Paolo Verdecchia and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E172–E176, https://doi.org/10.1093/eurheartj/suab116
Published: 08 October 2021
Journal Article
Clinical research methodology process: what is changing with COVID-19?
Luigi Tavazzi
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E161–E167, https://doi.org/10.1093/eurheartj/suab112
Published: 08 October 2021
Journal Article
How effective is cryoablation in the treatment of atrial fibrillation?
Diego Penela and Riccardo Cappato
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E51–E54, https://doi.org/10.1093/eurheartj/suab089
Published: 08 October 2021
Journal Article
New players in the treatment of hypercholesterolaemia: focus on bempedoic acid and inclisiran
Massimiliano Ruscica and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E59–E62, https://doi.org/10.1093/eurheartj/suab090
Published: 08 October 2021
Journal Article
Is physical activity always good for you? The physical activity paradox
Pier Luigi Temporelli
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E168–E171, https://doi.org/10.1093/eurheartj/suab115
Published: 08 October 2021
Journal Article
Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine
Felicita Andreotti and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E13–E18, https://doi.org/10.1093/eurheartj/suab084
Published: 08 October 2021
Journal Article
Thrombosis in pre- and post-vaccination phase of COVID-19
Francesco Violi and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E184–E188, https://doi.org/10.1093/eurheartj/suab118
Published: 08 October 2021
Journal Article
Renal arteries denervation: from the treatment of resistant hypertension to the treatment of atrial fibrillation
Francesco Versaci and others
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E177–E183, https://doi.org/10.1093/eurheartj/suab117
Published: 08 October 2021
Journal Article
The ISCHEMIA trial: optimal medical therapy against PTCA in the stable patient: the endless story
Andrea Santucci and Claudio Cavallini
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E55–E58, https://doi.org/10.1093/eurheartj/suab088
Published: 08 October 2021
Journal Article
Late primary angioplasty (beyond 12 h): are we sure it should be avoided?
Leonardo Bolognese
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E36–E39, https://doi.org/10.1093/eurheartj/suab086
Published: 08 October 2021
Journal Article
New prevention scenarios: polygenic risk
Alessandro Boccanelli and Giordano Bottà
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E33–E35, https://doi.org/10.1093/eurheartj/suab093
Published: 08 October 2021
Advertisement
Advertisement